Reprint

Disorders of Puberty: The Causes and the Endocrine Medical Treatment

The Causes and the Endocrine Medical Treatment

Edited by
September 2020
132 pages
  • ISBN978-3-03936-196-0 (Hardback)
  • ISBN978-3-03936-197-7 (PDF)

This book is a reprint of the Special Issue Disorders of Puberty: The Causes and the Endocrine Medical Treatment that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

How often is male idiopathic infertility diagnosed nowadays? It is estimated that 70% of male infertility is apparently idiopathic because its etiology cannot be found despite a complete diagnostic procedure. Epidemiological studies have highlighted that sperm concentration and total count have halved in the past forty years. The reasons for this decline are still unknown and, therefore, it is urgently necessary to research the etiopathogenetic moments. Given that Sertoli cells are responsible for supporting spermatogenesis, much attention should be focused on their function. During childhood, these cells have peculiar characteristics. After the onset of puberty, they reach a state of maturity and lose their ability to proliferate. Therefore, several environmental or lifestyle factors in childhood could reasonably interfere with the proliferation of Sertoli cells and this may be the cause of so-called idiopathic infertility in adulthood. For that reason, this book explores molecular aspects involving prepubertal Sertoli cells, risk factors for infertility in the early stages of life, and the correct management of andrological health from the first months of life and during infancy and adolescence. A close collaboration between pediatricians, endocrinologists, and andrologists is of fundamental importance to achieve an important goal: To protect the health of the fathers of tomorrow!

Format
  • Hardback
License
© 2020 by the authors; CC BY-NC-ND license
Keywords
Follicle-stimulating hormone; Insulin-like growth factor 1; Insulin-like growth factor 1 receptor; Sertoli cells; infertility; type 1 diabetes; asthenozoospermia; carnitine; primary prevention; male infertility; male transition; hypogonadism; oligozoospermia; substance abuse; drug abuse; alcohol; cigarette smoking; cannabis; amphetamines; opioids; anabolic-androgenic steroids; thyroid hormones; spermatozoa; sperm parameters; sperm mitochondrial potential; sperm motility; FSH; insulin; Sertoli cells; AMH; inhibin B; FSH; IGF1; GH; Sertoli cells; AMH; pediatric varicocele; testicular volume asymmetry; peak retrograde flow; varicocele repair; adolescent; lifestyle; fertility; transitional age; childhood cancer survivors; infertility; hypogonadism; testicular volume; azoospermia; chemotherapy; radiotherapy; stem cell transplantation; lymphoma; leukemia; Sertoli cells; Sertoli cell dysfunction; male infertility; inhibin B; AMH; IGF1; insulin